QC
OGN icon

Quadrature Capital’s Organon & Co OGN Stock Holding History

Quadrature Capital’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-103,395
Closed -$741K – 1720
2025
Q4 		$741K Buy
+103,395
New +$817K 0.01% 595
2021
Q4 		– Sell
-35,974
Closed -$1.18M – 868
2021
Q3 		$1.18M Buy
+35,974
New +$1.15M 0.04% 229

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
KBG
Kahn Brothers Group New York $633M AUM 39.01% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return

Quadrature Capital's OGN Position: Q1 2026 in Review

Quadrature Capital sold out of Organon & Co (OGN) in Q1 2026, closing a stake of 103,395 shares — an estimated $741K sold.

Quadrature Capital first reported a position in OGN in Q3 2021 and held it in 2 quarters. The position peaked at $1.18M in Q3 2021. 608 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Quadrature Capital reported no remaining Organon & Co position as of Q1 2026 after selling out during the quarter.
  • Quadrature Capital sold 103,395 Organon & Co shares in Q1 2026, an estimated $741K.
  • Quadrature Capital first reported a position in Organon & Co in Q3 2021 and held it in 2 quarters.
  • Quadrature Capital's Organon & Co position peaked at $1.18M in Q3 2021.
  • 608 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Quadrature Capital's 13F filing for Q1 2026, filed 15 May 2026.